Streetbeat News

Analyst Ratings

GRTS

Jones Trading analyst Catherine Novack has downgraded Gritstone Bio (NASDAQ:GRTS) from a Buy to a Hold rating.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:04 pm

NSC

Susquehanna analyst Bascome Majors maintains a Neutral rating on Norfolk Southern (NYSE:NSC) but raises the price target from $255 to $280.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:02 pm

GL

Seven analysts have recently assessed Globe Life (NYSE:GL), with a range of ratings from somewhat bullish to indifferent. The average 12-month price target has increased by 8.52% to $98.29. Analysts have raised their price targets, reflecting a positive sentiment shift. Globe Life shows strong financial performance with high net margins and ROE, but faces challenges in revenue growth compared to peers.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:02 pm

IREN

Iris Energy (NASDAQ:IREN), a Bitcoin mining company, has been evaluated by 15 analysts over the past three months. The majority of analysts are bullish, with an average 12-month price target of $16.27. Recent analyst actions include both maintaining and lowering price targets, reflecting dynamic market conditions. Iris Energy has shown significant revenue growth and maintains a strong financial position with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:01 pm

CSX

Susquehanna analyst Bascome Majors maintains a Positive rating on CSX and raises the price target from $41 to $42.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:01 pm

HRMY

Harmony Biosciences (NASDAQ:HRMY) has been analyzed by 6 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target is $52.67, with a high of $56.00 and a low of $52.00. The company has shown strong revenue growth and profitability, but its ROE is below industry benchmarks.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:01 pm

PAYX

In the past three months, analysts have shown varied sentiments towards Paychex (NASDAQ:PAYX), with most ratings being indifferent. The average 12-month price target has increased by 9.57% to $132.8. Analysts from firms like Morgan Stanley and Citigroup have raised their price targets, reflecting a positive outlook. Paychex's financials show strong revenue growth, net margin, and return on equity, indicating robust financial health.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:01 pm

ZIM

In the past three months, six analysts have provided ratings for ZIM Integrated Shipping (NYSE:ZIM), with a mix of bullish and bearish perspectives. The average 12-month price target is $18.53, slightly down from the previous $18.74. Analysts have adjusted their ratings and price targets, reflecting their views on ZIM's market performance. ZIM has shown strong revenue growth but faces challenges with net margin and debt management.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:00 pm

HAFC

Hanmi Financial (NASDAQ:HAFC) has been analyzed by four analysts, showing a range of perspectives from somewhat bullish to indifferent. The average 12-month price target has increased by 11.69% to $21.5. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments. Hanmi Financial faces challenges in revenue growth and return on equity but maintains a strong net margin and a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 1:00 pm

CP

Susquehanna analyst Bascome Majors maintains a Neutral rating on Canadian Pacific Kansas (NYSE:CP) but raises the price target from $80 to $94.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:00 pm